搜索临床试验以:TAK-828
总计5493个结果
-
Centro Mente Aberta de MindfulnessConselho Nacional de Desenvolvimento Científico e Tecnológico完全的
-
Hospital Universitari Vall d'Hebron Research InstituteParc Sanitari Sant Joan de Déu; Universitat Autonoma de Barcelona完全的
-
Craig James McClainNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完全的
-
National Institute of Allergy and Infectious Diseases...KBio Inc尚未招聘
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Rijnstate Hospital; Jeroen... 和其他合作者完全的
-
Duke UniversityUniversity of North Carolina, Chapel Hill; University of North Carolina, Greensboro; UConn Health完全的
-
Proteostasis Therapeutics, Inc.完全的
-
Medical University of ViennaMedical University of Graz尚未招聘
-
Hospital Universitari Vall d'Hebron Research InstituteUniversitat Autonoma de Barcelona招聘中
-
Universitat Internacional de CatalunyaInstitut Català d'Oncologia; Hospital Arnau de Vilanova; Fundacion Rioja Salud尚未招聘死亡 | 晚期癌症
-
University of SurreyUniversity of Nottingham; University of Sussex; University of Westminster招聘中
-
Arrowhead Pharmaceuticals完全的
-
Chinese University of Hong KongKing Chulalongkorn Memorial Hospital完全的
-
iHope Network, Inc.UConn Health; Woburn Pediatric Associates完全的
-
Merus N.V.招聘中含有 NRG1 融合基因的 NSCLC | 携带 NRG1 融合的实体瘤 | 携带 NRG1 融合基因的胰腺癌 | NRG1融合西班牙, 法国, 以色列, 比利时, 丹麦, 美国, 大韩民国, 日本, 德国, 荷兰, 奥地利, 加拿大, 意大利, 挪威, 新加坡, 瑞典, 台湾, 英国
-
Blood Purification Technologies, Inc.University of Washington; Wearable Artificial Kidney Foundation完全的
-
Emergent BioSolutionsUnited States Department of Defense完全的
-
Universitaire Ziekenhuizen KU Leuven招聘中
-
University of Dublin, Trinity CollegeMotor Neurone Disease Association, UK; Irish Research Council, IE; Thierry Latran Foundation, FR; ALS Association, USA 和其他合作者招聘中
-
Taiho Oncology, Inc.终止